Company profile
Denali Therapeutics Inc. Insider Trading
DNLIEvery SEC Form 4 insider trading filing for Denali Therapeutics Inc. (DNLI) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001714899
- Filings
- 124
- Insiders
- 21
- Last filing
- 2026-09-04
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $37K across 1 transaction.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Denali Therapeutics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $40.0M.
90 day insight
Over the last 90 days, Denali Therapeutics Inc. insiders sold $108K across 2 transactions with no open-market purchases.
- Most active insider: Nancy Thornberry with 2 transactions totaling $262K.
- Largest single sale: $247K by Nancy Thornberry on Sep 2, 2026.
- 60% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bearish — sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Peter Scott Chin | DNLI | Sale | 1,654 | $22.29 | $37K |
| Sep 2, 2026 | Nancy Thornberry | DNLI | Sale10b5 | 10,824 | $22.85 | $247K |
| Sep 2, 2026 | Nancy Thornberry | DNLI | Sale10b5 | 615 | $23.74 | $15K |
| Sep 1, 2026 | Alexander O. Schuth | DNLI | Sale10b5 | 2,768 | $23.44 | $65K |
| Aug 12, 2026 | Ryan J. Watts | DNLI | Gift | 32,220 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=DNLI" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Denali Therapeutics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →